A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.

M, Hafizi; S, Kalanaky; H, Moaiery; M, Khayamzadeh; S, Noorian; V, Kaveh; B, Gharib; H, Foudazi; M, Razavi; A, Jenabian; S, Salimi; MMA, Sereshki; HR, Mirzaei; A, Zarghi; S, Fakharzadeh; MH, Nazaran; ME, Akbari

doi:10.1186/s12951-019-0484-0

Public

A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.

Shared by NobleBlocks on Apr 10, 2019 • 12:00 AM UTC

Authors:

Hafizi M

Kalanaky S

Moaiery H

Abstract

<h4>Background</h4>Currently, the main goal of cancer research is to increase longevity of patients suffering malignant cancers. The promising results of BCc1 in vitro and vivo experiments made us look into the effect of BCc1 nanomedicine on patients with cancer in a clinical trial.<h4>Methods</h4>T...

Subject

Cancer

Gastric cancer

Clinical Trial

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!